The use of mitoxantrone in the treatment of breast cancer
Hainsworth, J.D.
Seminars in Oncology 22(1 Suppl 1: 17-20
1995
ISSN/ISBN: 0093-7754 PMID: 7863347 Document Number: 445996
Document emailed within 1 workday
Related Documents
Lenzhofer, R.; Rainer, H.; Schuster, R.; Pirker, P.; Dudczak, R.; Dittrich, C.; Moser, K. 1984: Mitoxantrone in the primary treatment of metastasizing breast cancer Wiener Klinische Wochenschrift 96(9): 319-326Holmes, F.A.; Yap, H.Y.; Esparza, L.; Buzdar, A.U.; Hortobagyi, G.N.; Blumenschein, G.R. 1984: Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer Seminars in Oncology 11(3 Suppl 1: 28-31
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984
Ehninger, G.; Weible, K.H.; Heidemann, E.G.; Waller, H.D. 1984: Mitoxantrone and cyclophosphamide in patients with advanced breast cancer Cancer Treatment Reports 68(10): 1283-1284
Follézou, J.Y.; Palangie, T.; Feuilhade, F. 1987: Randomized trial comparing mitoxantrone with adriamycin in advanced breast cancer Presse Medicale 16(16): 765-768
Burghouts, J.T. 1990: Mitoxantrone, methotrexate and chlorambucil in metastatic breast cancer, a combination with relatively low subjective toxicity Netherlands Journal of Medicine 36(1-2): 43-45
Vogel, C.L. 1995: Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review Seminars in Oncology 22(2 Suppl 5: 61-65
Ichikawa, W.; Osanai, T.; Shimizu, C.; Uetake, H.; Iida, S.; Yamashita, T.; Nishi, N.; Togo, S.; Miyanaga, T.; Nihei, Z.; Sugihara, K. 1998: Intra-arterial injection therapy of mitoxantrone for locally advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(9): 1333-1335
Ichikawa, W.; Nihei, Z.; Yamashita, T.; Sawai, S.; Shoji, Y.; Miyanaga, T.; Yoshinaga, K.; Hirayama, R.; Mishima, Y. 1993: Preoperative intra-arterial injection of mitoxantrone for locally advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(11): 1597-1600
Fiorentini, G.; Tsetis, D.; Bernardeschi, P.; Varveris, C.; Rossi, S.; Kalogeraki, A.; Athanasakis, E.; Dentico, P.; Kanellos, P.; Biancalani, M.; Almarashdah, S.; Zacharioudakis, G.; Saridaki, Z.; Chalkiadakis, G.; Xynos, E.; Zoras, O. 2003: First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer Anticancer Research 23(5b): 4339-4345
Katsumata, K.; Yamamoto, K.; Shibata, K.; Murano, A.; Kawasaki, M.; Moriwaki, R.; Nagakawa, Y.; Ogata, T.; Koyanagi, Y.; Kusama, M. 1997: Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(15): 2227-2232
Raina, V.; Sharma, A.; Deo, S.V.; Shukla, N.K.; Mohanty, B.K.; Goel, A.; Rath, G.K. 1998: Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage IIi (T4B, NO-2, M0) breast cancer Journal of the Association of Physicians of India 46(11): 926-929
Repetto, L.; Vannozzi, M.O.; Balleari, E.; Venturino, A.; Granetto, C.; Bason, C.; Simoni, C.; Prencipe, E.; Queirolo, P.; Esposito, M.; Ghio, R.; Rosso, R. 1999: Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells Anticancer Research 19(1b): 879-884
Misset, J.L.; Metz, R.; Gil-Delgado, M.; Keiling, R.; Cappelaere, P.; Armand, J.P.; Prévot, G.; Grimbert, J.; Mathé, G.; Hibberd, M. 1987: Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. a study of short-term response rate Anticancer Research 7(4b): 737-740
Nakagawa, M.; Schneider, E.; Dixon, K.H.; Horton, J.; Kelley, K.; Morrow, C.; Cowan, K.H. 1992: Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells Cancer Research 52(22): 6175-6181
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Izumi, M.; Iino, Y.; Yokoe, T.; Inoue, T.; Yamada, T.; Kobayashi, I.; Andoh, T.; Yokota, T.; Iijima, T.; Morishita, Y. 1994: Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 265-268
Topuz, E.; Saip, P.; Aydmer, A.; Salihoğlu, Y.; Berkman, S.; Bengisu, E. 1998: Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer European Journal of Gynaecological Oncology 19(3): 265-270
Genne, P.; Olsson, N.O.; Gutierrez, G.; Duchamp, O.; Chauffert, B. 1994: Liposomal mitoxantrone for the local treatment of peritoneal carcinomatosis induced by colon cancer cells in mice Anti-Cancer Drug Design 9(2): 73-84
DeSimone, P.A.; Gams, R.; Bartolucci, A. 1986: Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(7): 929-930